SKINBeauty Health Company (The) - Ordinary Shares - Class A

AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds PR Newswire BOCA RATON, Fla., June 23, 2026 Top 25 Brands Capture 95% of AI Citation Share; 11,500 Independent Med Spas...

Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

SkinHealth Systems Inc. (SKIN) delivered earnings and revenue surprises of +41.18% and -1.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has been given an average recommendation of 'Hold' by the eight analysts that are presently covering the stock, Marketbeat Ratings reports...

SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Beauty Health (NASDAQ:SKIN) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-the-beauty-health-company-stock...

Shares of The Beauty Health Company (NASDAQ:SKIN - Get Free Report) have received an average recommendation of "Hold" from the eight research firms that are presently covering the company, Marketbeat...